Investigating Intestinal Farnesoid X Receptor functions at the Intestinal Mucosal Barrier and in the Intestinal Microbiota in a Biliary Obstruction Mouse Model
{{output}}
Intestinal barrier dysfunction and dysbiosis are critical intestinal alterations in biliary obstructive diseases, for which FXR is a potential intestinal therapeutic target, but its roles and mechanisms in the intestinal tract remain poorly defined. Using gut-... ...
